NasdaqGS - Delayed Quote • USD
Amedisys, Inc. (AMED)
At close: April 24 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 12 | 9 |
| Avg. Estimate | 1.02 | 1.25 | 4.56 | 5.01 |
| Low Estimate | 0.92 | 1.04 | 4.35 | 4.5 |
| High Estimate | 1.09 | 1.51 | 4.82 | 5.73 |
| Year Ago EPS | 1 | 1.37 | 4.3 | 4.56 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 12 | 9 |
| Avg. Estimate | 565.38M | 574.69M | 2.32B | 2.46B |
| Low Estimate | 555.9M | 568.46M | 2.29B | 2.37B |
| High Estimate | 580.86M | 582.61M | 2.36B | 2.55B |
| Year Ago Sales | 556.39M | 552.97M | 2.24B | 2.32B |
| Sales Growth (year/est) | 1.60% | 3.90% | 3.70% | 5.90% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.88 | 1.09 | 1.08 | 1.03 |
| EPS Actual | 1 | 1.37 | 0.98 | 0.94 |
| Difference | 0.12 | 0.28 | -0.1 | -0.09 |
| Surprise % | 13.60% | 25.70% | -9.30% | -8.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.02 | 1.25 | 4.56 | 5.01 |
| 7 Days Ago | 1.02 | 1.25 | 4.56 | 5.01 |
| 30 Days Ago | 1.01 | 1.22 | 4.55 | 5 |
| 60 Days Ago | 0.99 | 1.16 | 4.5 | 4.97 |
| 90 Days Ago | 0.99 | 1.15 | 4.52 | 5.02 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | AMED | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 2.00% | -- | -- | 1.50% |
| Next Qtr. | -8.80% | -- | -- | 11.40% |
| Current Year | 6.00% | -- | -- | 5.20% |
| Next Year | 9.90% | -- | -- | 13.40% |
| Next 5 Years (per annum) | 4.68% | -- | -- | 11.09% |
| Past 5 Years (per annum) | -0.50% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Raymond James: Market Perform to Market Perform | 3/26/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 3/25/2024 |
| Maintains | Cantor Fitzgerald: Neutral to Neutral | 9/14/2023 |
| Maintains | TD Cowen: Market Perform to Market Perform | 7/31/2023 |
| Reiterates | Credit Suisse: Neutral to Neutral | 7/27/2023 |
| Downgrade | Jefferies: Buy to Hold | 7/6/2023 |
Related Tickers
ADUS Addus HomeCare Corporation
95.50
+0.78%
CHE Chemed Corporation
617.95
+0.23%
EHC Encompass Health Corporation
82.80
+0.41%
MD Pediatrix Medical Group, Inc.
9.24
-1.70%
NHC National HealthCare Corporation
91.13
-0.05%
ACHC Acadia Healthcare Company, Inc.
71.19
+0.64%
SEM Select Medical Holdings Corporation
27.72
-1.60%
ENSG The Ensign Group, Inc.
118.64
+0.02%
FCHS First Choice Healthcare Solutions, Inc.
0.0040
0.00%
HCSG Healthcare Services Group, Inc.
11.22
-6.11%